Amolyt Pharma
5 Podcast Episodes
A Rare (Disease) Opportunity: Amolyt Pharma – Targeting Orphan Diseases of the Endocrine System
A Rare (Disease) Opportunity: Amolyt Pharma – Targeting Orphan Diseases of the Endocrine System
Having focused on endocrine disorders since grad school, first at the bench and later in the board room, Dr. Thierry Abr... Read more
14 Apr 2022
•
36mins
782: When Operations Came First | Lou Arcudi, CFO, Amolyt Pharma
782: When Operations Came First | Lou Arcudi, CFO, Amolyt Pharma
To those well familiar with the career milestones that typically mark the path to the CFO office, Lou Arcudi’s resume at... Read more
9 Mar 2022
•
1hr 8mins
Similar People
Mark Allen
David Katz
Rosalind Picard
David Solomon
Matt Murphy
Robin Smith
Thomas Cowan
Greg Miller
Travis Mickle
Justin Miller
Sean Tucker
Matt Wilson
Chris Young
Jim Martin
Robin Zander
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
Amolyt Pharma is developing a therapeutic peptide program targeting rare endocrine and metabolic diseases including hyp... Read more
8 Mar 2021
•
36mins
Dr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseases
Dr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseases
We sit down and talk to Dr. Abribat about Amolyt Pharma, which is developing therapeutic peptides to treat rare endocrin... Read more
20 Jan 2021
•
16mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Developing Peptides for Hypoparathyroidism and Other Rare Endocrine and Metabolic Disorders with Thierry Abribat Amolyt Pharma
Developing Peptides for Hypoparathyroidism and Other Rare Endocrine and Metabolic Disorders with Thierry Abribat Amolyt Pharma
Thierry Abribat, Founder and CEO, Amolyt Pharma is developing a portfolio of products of peptides for rare endocrine and... Read more
29 Jun 2020
•
18mins
